|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 20, 2017 ) The global empty capsules market is estimated to grow at a CAGR of 7.2% during the forecast period, to reach USD 2.13 Billion by 2021. The rapidly increasing aging population, growing applications in the pharmaceutical and nutraceutical industries, and growing consumer preference towards capsule-based formulations are the major factors driving the growth of the market. However, increasing raw material prices, stringent regulatory frameworks, and religious as well as cultural specifications are expected to limit the growth of this market to a certain extent. <||>rnhttp://www.marketsandmarkets.com/Market-Reports/empty-capsules-market-218018190.html
In this report, the empty capsules market is segmented on the basis of products, therapeutic applications, end users, and regions. Based on products, the market is subsegmented into gelatin and non-gelatin capsules. In 2015, the gelatin capsules segment accounted for the largest share of the global market. The large share of this segment is mainly due to factors such as the development of a wide range of formulations using hard gelatin capsules as a simple form for oral drug delivery and increasing use of gelatin capsules in novel drug delivery systems with modified and targeted drug-release properties. The non-gelatin capsules segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment is mainly due to strict government regulations regarding the use of animal-derived gelatin in pharmaceutical and nutraceutical products, dietary sensitivity of patients, and drug incompatibilities with gelatin capsules.
Based on therapeutic applications, the empty capsules market is subsegmented into antibiotic and antibacterial drugs, vitamins and dietary supplements, antacid and antiflatulent preparations, antianemic preparations, anti-inflammatory and anti-rheumatic drugs, cardiac therapy drugs, cough and cold preparations, and other therapeutic applications. The antibiotic and antibacterial drugs segment accounted for the largest share of the global empty capsules market in 2015. Based on end users, the market is subsegmented into the pharmaceutical industry, nutraceutical industry, cosmetics industry, and research laboratories. The pharmaceutical industry accounted for the largest share of the market in 2015.
Request Sample Pages@ http://www.marketsandmarkets.com/requestsample.asp?id=218018190
Geographically, the empty capsules market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded a major share of the market. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to growth in the pharmaceutical and nutraceutical industries along with less stringent regulations in the nutraceutical industry, increasing number of new healthcare facilities, and rising healthcare awareness.
The prominent players in the global empty capsules market include ACG Worldwide (India), Capsugel (U.S.), CapsCanada Corporation (Canada), Qualicaps, Inc. (U.S.), Suheung Co., Ltd. (Korea), Medi-Caps Ltd. (India), Roxlor LLC (U.S.), Bright Pharma Caps (U.S.), Snail Pharma Industry Co., Ltd. (China), and Sunil Healthcare Ltd.(India).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
MarketsandMarkets
Mr. Rohan
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
